Table 1. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Restraints

Table 3. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Trends

Table 4. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Industry Policy

Table 5. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 9. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)

Table 10. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Mergers & Acquisitions, Expansion Plans

Table 12. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Manufacturers Product Type

Table 13. Head Office and Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Production Site of Key Manufacturer

Table 14. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Capacity of Major Manufacturers and Future Plan

Table 15. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 16. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022

Table 17. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity by Company, 2018-2023, Ranked by Data of 2022

Table 18. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 19. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Production by Region, 2018-2023, (K Units)

Table 20. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Upstream (Raw Materials)

Table 22. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Typical Customers

Table 23. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Typical Distributors

Table 24. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 25. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 26. By Region, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 27. By Region, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value, 2018-2029, US$ Million

Table 28. By Region, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Table 29. By Country, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Country, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value, 2018-2029, US$ Million

Table 31. By Country, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value Market Share, 2018-2029

Table 32. By Country, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Table 33. By Country, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2018-2029

Table 34. Takeda Pharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 35. Takeda Pharmaceutical Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 36. Takeda Pharmaceutical Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 37. Takeda Pharmaceutical Company Profile and Main Business

Table 38. Takeda Pharmaceutical Recent Developments

Table 39. Baxter International Inc. Company Information, Head Office, Market Area, and Industry Position

Table 40. Baxter International Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 41. Baxter International Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Baxter International Inc. Company Profile and Main Business

Table 43. Baxter International Inc. Recent Developments

Table 44. CSL Behring Company Information, Head Office, Market Area, and Industry Position

Table 45. CSL Behring Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 46. CSL Behring Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. CSL Behring Company Profile and Main Business

Table 48. CSL Behring Recent Developments

Table 49. Bayer AG Company Information, Head Office, Market Area, and Industry Position

Table 50. Bayer AG Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 51. Bayer AG Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Bayer AG Company Profile and Main Business

Table 53. Bayer AG Recent Developments

Table 54. Grifols, S.A. Company Information, Head Office, Market Area, and Industry Position

Table 55. Grifols, S.A. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 56. Grifols, S.A. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Grifols, S.A. Company Profile and Main Business

Table 58. Grifols, S.A. Recent Developments

Table 59. Octapharma AG Company Information, Head Office, Market Area, and Industry Position

Table 60. Octapharma AG Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 61. Octapharma AG Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Octapharma AG Company Profile and Main Business

Table 63. Octapharma AG Recent Developments

Table 64. Taibang Biologic Group Company Information, Head Office, Market Area, and Industry Position

Table 65. Taibang Biologic Group Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 66. Taibang Biologic Group Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Taibang Biologic Group Company Profile and Main Business

Table 68. Taibang Biologic Group Recent Developments

Table 69. Pacific Shuanglin Bio-pharmacy Company Information, Head Office, Market Area, and Industry Position

Table 70. Pacific Shuanglin Bio-pharmacy Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 71. Pacific Shuanglin Bio-pharmacy Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Pacific Shuanglin Bio-pharmacy Company Profile and Main Business

Table 73. Pacific Shuanglin Bio-pharmacy Recent Developments

Table 74. Shenzhen Weiguang Biological Products Company Information, Head Office, Market Area, and Industry Position

Table 75. Shenzhen Weiguang Biological Products Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 76. Shenzhen Weiguang Biological Products Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Shenzhen Weiguang Biological Products Company Profile and Main Business

Table 78. Shenzhen Weiguang Biological Products Recent Developments

Table 79. Nanjing Pharmacare Co.,Ltd Company Information, Head Office, Market Area, and Industry Position

Table 80. Nanjing Pharmacare Co.,Ltd Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 81. Nanjing Pharmacare Co.,Ltd Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Nanjing Pharmacare Co.,Ltd Company Profile and Main Business

Table 83. Nanjing Pharmacare Co.,Ltd Recent Developments

Table 84. Shanghai RAAS Company Information, Head Office, Market Area, and Industry Position

Table 85. Shanghai RAAS Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 86. Shanghai RAAS Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Shanghai RAAS Company Profile and Main Business

Table 88. Shanghai RAAS Recent Developments

Table 89. Harbin Pacific Biopharmaceutical Company Information, Head Office, Market Area, and Industry Position

Table 90. Harbin Pacific Biopharmaceutical Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 91. Harbin Pacific Biopharmaceutical Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Harbin Pacific Biopharmaceutical Company Profile and Main Business

Table 93. Harbin Pacific Biopharmaceutical Recent Developments

Table 94. Hualan Biological Engineering Inc. Company Information, Head Office, Market Area, and Industry Position

Table 95. Hualan Biological Engineering Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 96. Hualan Biological Engineering Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Hualan Biological Engineering Inc. Company Profile and Main Business

Table 98. Hualan Biological Engineering Inc. Recent Developments

Table 99. China Biologic Products, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 100. China Biologic Products, Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 101. China Biologic Products, Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. China Biologic Products, Inc. Company Profile and Main Business

Table 103. China Biologic Products, Inc. Recent Developments

Table 104. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 105. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 106. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Profile and Main Business

Table 108. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments

Table 109. Boya Bio-Pharmaceutical Group Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 110. Boya Bio-Pharmaceutical Group Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 111. Boya Bio-Pharmaceutical Group Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 112. Boya Bio-Pharmaceutical Group Co., Ltd. Company Profile and Main Business

Table 113. Boya Bio-Pharmaceutical Group Co., Ltd. Recent Developments

Table 114. ADMA Biologics, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 115. ADMA Biologics, Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 116. ADMA Biologics, Inc. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 117. ADMA Biologics, Inc. Company Profile and Main Business

Table 118. ADMA Biologics, Inc. Recent Developments

Table 119. Sinopharm Group Co., Ltd. Company Information, Head Office, Market Area, and Industry Position

Table 120. Sinopharm Group Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Models, Specifications, and Application

Table 121. Sinopharm Group Co., Ltd. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 122. Sinopharm Group Co., Ltd. Company Profile and Main Business

Table 123. Sinopharm Group Co., Ltd. Recent Developments

List of Figures

Figure 1. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Picture

Figure 2. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value, (US$ million) & (2018-2029)

Figure 3. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, (K Units) & (2018-2029)

Figure 4. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Average Selling Price (ASP), (2018-2029) & (US$/Unit)

Figure 5. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value, (US$ million) & (2018-2029)

Figure 6. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity (K Units) & (2018-2029)

Figure 7. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Average Selling Price (ASP), (US$/Unit) & (2018-2029)

Figure 8. By Consumption Value, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share of Global, 2018-2029

Figure 9. By Sales Quantity, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share of Global, 2018-2029

Figure 10. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Key Participants, Market Share, 2022

Figure 12. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Capacity, Production and Capacity Utilization, 2018-2029

Figure 13. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Production Market Share & Forecast by Region, 2018-2029

Figure 15. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Industry Chain

Figure 16. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Procurement Model

Figure 17. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Model

Figure 18. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Channels, Direct Sales, and Distribution

Figure 19. 1.25g

Figure 20. 2.5g

Figure 21. 5g

Figure 22. Others

Figure 23. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value, 2018-2029, US$ Million

Figure 24. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value Market Share, 2018-2029

Figure 25. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Figure 26. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2018-2029

Figure 27. By Type, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 28. Hospitals

Figure 29. Clinics

Figure 30. Others

Figure 31. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value, 2018-2029, US$ Million

Figure 32. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value Market Share, 2018-2029

Figure 33. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Figure 34. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2018-2029

Figure 35. By Application, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Average Selling Price (ASP), 2018-2029, (US$/Unit)

Figure 36. By Region, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value Market Share, 2018-2029

Figure 37. By Region, Global Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2018-2029

Figure 38. North America Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 39. By Country, North America Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value Market Share, 2022

Figure 40. Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 41. By Country, Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value Market Share, 2022

Figure 42. Asia Pacific Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 43. By Country/Region, Asia Pacific Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value Market Share, 2022

Figure 44. South America Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 45. By Country, South America Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value Market Share, 2022

Figure 46. Middle East & Africa Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 47. U.S. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Figure 48. By Type, U.S. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 49. By Application, U.S. Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 50. Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Figure 51. By Type, Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 52. By Application, Europe Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 53. China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Figure 54. By Type, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 55. By Application, China Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 56. Japan Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Figure 57. By Type, Japan Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 58. By Application, Japan Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 59. South Korea Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Figure 60. By Type, South Korea Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 61. By Application, South Korea Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 62. Southeast Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Figure 63. By Type, Southeast Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 64. By Application, Southeast Asia Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 65. India Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Figure 66. By Type, India Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 67. By Application, India Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 68. Middle East & Africa Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity, 2018-2029, (K Units)

Figure 69. By Type, Middle East & Africa Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 70. By Application, Middle East & Africa Lyophilized Human Immunoglobulin (PH4) for Intravenous Injection Sales Quantity Market Share, 2022 VS 2029

Figure 71. Research Methodology

Figure 72. Breakdown of Primary Interviews

Figure 73. Bottom-up and Top-down Approaches

Figure 74. Top-down Approaches